Sanofi Return On Equity from 2010 to 2024

SNY Stock  USD 48.28  0.30  0.63%   
Sanofi ADR Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Sanofi ADR in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.07293355
Current Value
0.13
Quarterly Volatility
0.04125852
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 607 M or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 3.95, Dividend Yield of 0.0232 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Sanofi ADR over the last few years. Return on Equity is the amount of Sanofi ADR net income returned as a percentage of Sanofi ADR equity. Return on equity measures Sanofi ADR profitability by revealing how much profit Sanofi ADR generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Sanofi ADR's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.058210 Years Trend
Very volatile
   Return On Equity   
       Timeline  

Sanofi Return On Equity Regression Statistics

Arithmetic Mean0.1
Geometric Mean0.09
Coefficient Of Variation42.60
Mean Deviation0.03
Median0.08
Standard Deviation0.04
Sample Variance0
Range0.1475
R-Value0.02
Mean Square Error0
R-Squared0.0003
Significance0.95
Slope0.0002
Total Sum of Squares0.02

Sanofi Return On Equity History

2024 0.13
2023 0.0729
2022 0.11
2021 0.0906
2020 0.2
2019 0.0476
2018 0.0731

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity 0.07  0.13 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.